Apr 27 |
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
Apr 26 |
Gilead Sciences declares $0.77 dividend
|
Apr 26 |
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
|
Apr 26 |
Q1 2024 Gilead Sciences Inc Earnings Call
|
Apr 26 |
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
|
Apr 26 |
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
|
Apr 26 |
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
|
Apr 26 |
Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript
|
Apr 26 |
Gilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
|
Apr 25 |
Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus
|